Please ensure Javascript is enabled for purposes of website accessibility

Why Shares of Chemours Rocketed 30.3% in April

By Maxx Chatsko - May 11, 2016 at 11:51AM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Performance chemicals leader Chemours saw shares climb higher last month after improvements in key markets. Here's what you need to know.

CC Chart

CC data by YCharts

What: Industrial and specialty chemicals company Chemours (CC -1.58%) saw shares gain nearly one-third last month, continuing a steady streak of stock gains that began in late January, after a string of good news. Most of the gains came on the heels of a rise in global metals prices, including silver and gold, for which the company provides a critical processing chemical.

So what: The DuPont spinoff is the world's largest producer of fluoroproducts (including Teflon, disinfectants, and water membranes), titania (used in everything from sunscreen to paint), and sodium cyanide. The latter is a critical consumable for gold and silver processing -- and Chemours supplies nearly 45% of the market in North and South America. So any bump in gold and silver prices that could lead to increased mining and production will translate into an increase in sales for the company's unit. With renewed hopes that Brazil's fast-growing economy can get back on track, investors are hoping that higher precious-metal prices are here to stay.

There were other material advances last month. Chemours sold its disinfectant business -- responsible for $110 million in annual revenue -- to Lanxess for $230 million in cash. The company also announced that it was increasing the selling price of all titania products by $150 per metric ton, which will add up for the 1.25 million metric tons of annual production capacity under its control.

Now what: There's no denying that Chemours is a global leader in performance chemicals. However, it's had a challenging, albeit short, life on the public markets and currently trades at less than half of its IPO price from summer 2015. Given that revenue has steadily decreased in each of the past five years, I would be wary about investing in the company until growth is proven.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

The Chemours Company Stock Quote
The Chemours Company
$31.23 (-1.58%) $0.50
E. I. du Pont de Nemours and Company Stock Quote
E. I. du Pont de Nemours and Company

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 06/29/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.